Advances in lipoprotein and atherosclerosis research: diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991
Gespeichert in:
Format: | Tagungsbericht Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Jena ; Stuttgart ; New York
<<G.>> Fischer
1991
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | Literaturangaben |
Beschreibung: | 426 S. Ill., graph. Darst. |
ISBN: | 3334603970 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV004690868 | ||
003 | DE-604 | ||
005 | 20060908 | ||
007 | t | ||
008 | 911216s1991 ad|| |||| 10||| eng d | ||
020 | |a 3334603970 |9 3-334-60397-0 | ||
035 | |a (OCoLC)28115990 | ||
035 | |a (DE-599)BVBBV004690868 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-19 |a DE-12 |a DE-M49 | ||
084 | |a OEK 412f |2 stub | ||
084 | |a MED 441f |2 stub | ||
245 | 1 | 0 | |a Advances in lipoprotein and atherosclerosis research |b diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991 |c ed.: M. Hanefeld ... |
264 | 1 | |a Jena ; Stuttgart ; New York |b <<G.>> Fischer |c 1991 | |
300 | |a 426 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Literaturangaben | ||
650 | 4 | |a Arteriosclerosis |x diagnosis |v Congresses | |
650 | 4 | |a Arteriosclerosis |x etiology |v Congresses | |
650 | 4 | |a Arteriosclerosis |x therapy |v Congresses | |
650 | 4 | |a Lipoproteins |x metabolism |v Congresses | |
650 | 0 | 7 | |a Arteriosklerose |0 (DE-588)4068866-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Hyperlipidämie |0 (DE-588)4161072-6 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1991 |z Dresden |2 gnd-content | |
689 | 0 | 0 | |a Arteriosklerose |0 (DE-588)4068866-5 |D s |
689 | 0 | 1 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Arteriosklerose |0 (DE-588)4068866-5 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Hanefeld, Markolf |d 1935- |e Sonstige |0 (DE-588)105670286 |4 oth | |
711 | 2 | |a International Dresden Lipid Symposium |n 7 |d 1991 |c Dresden |j Sonstige |0 (DE-588)2120580-2 |4 oth | |
856 | 4 | 2 | |m Digitalisierung TU Muenchen |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002879788&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-002879788 |
Datensatz im Suchindex
_version_ | 1804118806006595584 |
---|---|
adam_text | Contents
Plenary Lectures
I· . 11. Epstein (Zurich):
Rise and Fall in Coronary Heart Disease; Is it due to Changes in Major Risk
Fanors?
.....................................
II
I.. Chan (Houston):
Recent
Advances in the Molecular Genetics of Lipoprotein Metabolism
... 19
1).
Kritchevsky (Philadelphia):
Dietary Fiber in I.ipid Metabolism and Atherosclerosis
............ 24
Non-Pharmaceutical Treatment of Dyslipoproteinetnia
W. Szosiak, W. Sekula (Warsaw):
Changes in
Nutľiiion
Habits in Poland. Impact on Coronary Heart Disease
Epidemiology
.................................. 32
G. Riccardi, G. Amiuzzi (Naples):
Are High (Carbohydrate Diets
Adequale
for the Correction of Coronary Risk
Factors?
..................................... 38
S.
Heyden,
К. Л.
Schneider (Durham);
Non-
Pharmacological
Treatment
of Dyslipoproteineniias (Low HDL Levels).
44
R. Carnicnu (Valencia):
Mono-Ene
Fatty Acids in
lhe
Prevention
oí
Dyslipoproteinemia and Athero¬
sclerosis
..................................... 50
I.
Klimeš,
E.
Sebokova, A. Mincenko,
A. Vrana,
M.
Fickóvá,
M.
Hromadova,
F..
Svahová,
P. Bohev,
L.
Kazdova
(Bratislava,
Kiew,
Prague):
Dietary Fish Oil in Hyperlipidemia and Impaired Insulin Action
-
The
Experimental Approach.
A
Minireview.................... 56
V. Herrmann, J.
Biermann,
К.
-P.
Raumann,
H.-G. Lindhofer
(Meiningen,
Bad
Collx-rg,
Berlin):
Ηί ιτι
oľ
Fish Oil Concentrate on
lhe
l.ipoproicin Profile in Patients Suffe¬
ring from
Diabetes Melliuis
Type II
...................... 63
P. Singer (Lindenlels):
Lipid-
and Blood Pressure
-
Lowering Effect of Omega-3 Fatty Acids
-
a
Provisional Appraisal
.............................. 70
G, W.
Meijer,
J. G. P. Van
der Palen,
L. F. M. Van Zutphen, A. C. Beynen
(Utrecht):
Cholesterol Metabolism in Rabbits Hypo- or Hyperresponsive to Dietary
Cholesterol
................................... 74
K. Kisters, C.
Spieker,
С.
Karoff,
К.
Rahn, W. Zidek (Münster):
Elicci
oían
Oral Magnesium Supplementation on Atherogenic Risk Factors
. 79
К.
Oeue, H.
Borberg,
J.
Kadar,
E.
Godehardt (Köln):
Long-Term
Exlracorporeal LDL
Elimination in the Treatment
»f Hyper¬
cholesterolemia
-
Effects and Clinical Relevance
...............
84
Y. Scholtenfeld-Naor, M. Leschkc. W. Kleophas, H. Hauncr, F. A. dries
(Düsseldorf):
Long-Term
He-parin-Induced Exiracorporal LDL-Precipilalion (HELP) in
Patients wilh Familial Heterozygous Hypcrlipoproteinemia and
Ad vant
ed
Coronary Artery Disease
.............................
°
V. Kohl, J.
Barth,
M.
Hnnefeld,
К.
Fucker (Dresden):
Effects of Artificial
U
V-Irradiation on Serum Lipids and Blood Circulation
. 93
Lipid
Lowering Drugs
P. Schwandt (Munich):
Drug Treatment of Hypercholesterolemia
................... $8
M. Hanefcld (Dresden):
Hypeririglyceridemia: When and How to Treat?
............... 104
B.
Idxior-Walus,
A. Zdûenfcku,
Ζ.
Sekula,
W.
Rostworosvski
(Krakow):
Changes in Concentration of Insulin and
Cortisol
and Plasma
Lipid
(Concen¬
tration upon Treatment with LovvisUitm of
Ну
perlí pideiiik
Patients
.....
ПО
C. Luley, K.-J.
Krüger,
M.
Schumacher,
H,
Riedel, F.. Kaplan,
H.
Klor
(Freiburg, Gießen);
Plasma Lipids in
6255
Hyperlipidemic Patients upon Treatment with
Acipimox (Olbemox) Tor Two Years
......................
ИЗ
С,
Α.
Feldstein (Buenos Aires):
Kffects
of Different
Anlihypertensive
Drugs on Coronary Risk Factor Profile
116
E.
Keller, IS.
Kunnen,
Α.
Trübsbach,
V.
Richter,
Α.
Naumann, W. Braun,
T. Hiľschbeng, A. Liebrenz
(Leipzig, Dresden, Erfurt):
Treatment of Patients with Cholesterol Ester Storage Disease with
HMG-CoA Rcductase Inhibitor
Lovastalin
................... 123
Clinical Application of
DNA
Analysis in Dyslipoproteinemia
С
Assmann,
A. v. Eckardtstein, H.
Funke (Münster):
Role of Apolipoproiein and
Lipid
Transfer Enzyme Mutants in High
Density Lipoprotein Metabolism
........................ 126
ll.-J. Menzel,
I. Pfiischer (Insbruck):
Molecular Aspects of Apolipoprotein (a) Polymorphism
............ 135
R.
Poledne,
2.
Pisa, K. Berg (Prague, Oslo):
Contribution of Low Density Lipoprotein Receptor
Cene
Polymorphism to
Hypercholesterolemia in Children
.......................
HI
S.
Gehrisch, W. Jaroß
(Dresden);
Associations Between Several
Apolipoproiein
В
and
F. Mutations
and the
Expression of Coronary Atherosclerosis
.................... 145
VI
M. Menschikowski, G. Dinncbicr, M.
Hartwig,
A. v. Eckardstein, C. Schon-
fcls, IJ.
Laliké,
С
Gens, W.
Jarnß (Dresden, Münster):
Apo
А
-l
Variants Found in Two Unrelated Families of Dresden
....... 151
R.
Schäret-,
О.
Rader,
R.
Gregg,
F. Thomas,
L.
Zech,
M.
Kindt,
M.
Benson,
H.
Kaíľarnik, H,
Brewer (Belhesda, Marburg):
In vivo Kinetics of
a M
ulani
Form of
Apo
AI,
Apo
AI [Iowa] (Gly-.c.- -Arg)
Utilizing
lhe
Stable
Isotope
Approach with
^Cß-L-Phenyhilanine....... 15 !
Diagnostic and Prognostic Relevance of Lipoprotein Parameters
W. F.
Riesen (Si. Gallen):
Diagnostic Value of Several
Lipoprotein
Constituents for CHD Risk
Estimation
.................................... 157
L.
Heinemann,
I. Martin (Berlin, Geneve):
MONICA Risk Factor Data in Europe
..................... 162
W.
Jaroß,
И.
Schulte, S. Bergmann,
G.
Assmann, DRECAN-Teani (Dresden,
Münster):
Differences ¡n Risk Profile Between People from East and West
Germany (DRECAN-PROCAM Comparison)
................. 171
S.
Bergmann,
T. Freidt,
1-І.
Scimi idi-
Petersen (Dresden):
Tracking of Dyslipoproieinemia ¡n Early Childhood
.............. 179
1-І. Schulte,
G.
Assmann (Münster):
The PROCAM
Study and Consequences for a Health Promotion Program
. . 185
H. Holtz, S. Domarkicne, J.
Heinrich,
S.
Brasche,
W.
Barth, J. Knappe,
J.
Blushaz (Erfurt, Berlin, Kaunas, Wuppertal):
Prognostic Importance of Mild Hyperlipidemia. Results from Two Prospec¬
tive Studies tvith
10
and
15
Years Follow-up
.................. 188
C. Gens, M. Menschikowski,
P. Lattke, G. Dinnebier, S.
Gehrisch,
A. Kle¬
ment,
W.
Jaroli (Dresden):
Comparison of Several HDL Parameters in Discriminating Between Subjects
with Different Risk for Myocardial Infarction
................. 191
E.
Tvracka, P. Mares (Prague):
Chromatographie
Methods in
Lipici
and Lipoprotein Research
........ 195
Hyperlipidemia in the Elderly and Lipoprotein Modifications
A. Klimov (Leningrad):
Autoimmune Theory of Atherogenesis and Conception
oí
Modified Lipo-
p
rotei
ns
..................................... 201
M.
Bihari-
Varga
(Budapest):
Modified Lipoproieins and the Arterial Wall in
lhe
Elderly
.......... 207
G. Kinsman, A. Howard, D. Stone, P. Mullins, Y. Yamori (Cambridge,
I
zumo):
Studies of Copper Status in Relation to
Lipoprotéine
and Atherosclerosis.
. . 212
VII
R. Rauľamua, A.
Lehtonen (Kuopio, Turku);
Rationale of Physical Exercise in the Prevention of Atherosclerosis in the
Elderly
...................................... -18
C. A.
Feldstein (Buenos
Aires):
The
Lipid
Awareness Program
. . ,...................... 221
V. Richter,
F. Rassoul,
T.
Pure/, I. Morwinski,
С.
Klein (Leipzig):
HDL
Subfractions
in Dependence on Aging
.................. 227
Cholesterol Transport
A. Steinmcu (Marburg):
Apolipoprotein A IV and Reverse Cholesterol Transport
........... 232
H. Dicplinger, K. Williamson,
F. Kronenberg,
К.-
M.
Lobentan/.,
G,
Seli
m
it./
(Innsbruck, Münster):
Cholesterylester Transfer Protein
and Reversed Cholesterol Transport in
Human Plasma................................. 238
S. Ľísenberg, E. Sehayek
(Jerusalem):
VLDL
(Apo Ľ)
Receptors and Cellular Metabolism
.............. 244
T. Olivecrona, G. Bengtsson-Olivecrona, R.
Deckelbaum
(Urnea,
New York):
What
Regulales
Lipase
Action on Lipoproteins?
................ 250
Y. A.
KesÜniemi,
T.
A, Mietimeli (Oulu, Helsinki):
Catabolism of Low Density Lipoprotein Apoprotein
В
in Individuals with
Different Apoproiein
К
Phenotypes
...................... 256
G.
Schmilz,
T.
Brüning,
Ľ.
Williamson
(Regensburg):
Cholesterol Metabolism in
Macrophages
Influenced by High Density Lipo-
proieins
..................................... 262
A. v. Kckardstein, M. Waller, A. Roeirige, G. Assmann
(Münster);
Methionine Sulfoxidaiion of
Apo
A I: Impact of Interactions of HDL with
LDL and Cells
.................................. 272
V. V. Tertov, I. A, Sobenin, A.
N.
Orekhov (Moscow):
Lipid
Composition o( Atherogenic Desialylaled Low Density Lipoproteins
, .
27Г)
Diabetes, Dyslipoproteinemia and Atherosclerosis
U. Julius (Dresden);
Epidemiology of Dyslipoproteinemia in Diabetes Melliuis
........... 280
Ľ.
Stancll,
H. U. Janka, H.
Stiegler,
П.
Mehneri (Munich):
Hyperinsulmemia as an Indicator of Risk for Macrovascular Disease in
NIDDM
..................................... 286
M. Uusitupa:
Obesity. Hypertension and Insulin Resistance-Impact of Atherogenesis
. . . 291
D. Pometla, R.James (Geneve);
DyslipoproU inemias and Type II Diabetes: Subclasses and Plasma
Trigly¬
cérides
...................................... 296
VIII
K.-j.
Krüger,
С.
Luley,
M. Schumacher, H.
Rieder,
E.
Kaplan,
H.
Klör
(Freiburg,
Gießen):
Iniprovemeiu
оГ
Blood Glucose and Uric Acid in
1434
Diabetic Patients
under Treatment with Acipimox (Olbemox) for Two Years
.......... 302
Progression and Regression in Atherosclerosis
I. Siemens, T. Simon, U.
Hamberger,
D. Grebeľ,
G.
Wiest,
D.
Osiertag-
Körner, G. Mall, I. Pedal (Heidelberg):
Morphometric
Investigation of Coronary Arteries and Capillaries of
Myocardium: Evidence for Early Sex and Age Related Changes
....... 305
J. A. Castillo, J. Fernandez-Britto, j.
Bacallao,
R.
Campos,
R.
Wong
(Havana):
Atherosclerosis Progression Related to Hypertension: A Pathomorpho-
logical and Morphometric Study Using an Alherometric System
....... 308
J. Fernandez-Britto, J.
Bacallao,
J. A. Castillo, R. Campos, R. Wong
(Havana):
Atherosclerosis
Ín
Diabetes and other Diseases: A Comparative Morpho¬
metric Study of their Progression Using an Atherometric System
....... 314
A. G. Olsson (Linköping):
Regression o/ Human Atherosclerosis
..................... 322
D. Kramsch, D. Blankenhorn,
1-І.
Hodis (Los Angeles):
New Treatment Directions in Arteriosclerolic Arterial Disease
........ 328
Obesity, Energy Metabolism and Dyslipoproteinemia
H. Ditschuneit,
M. H.
Ditschuneil
(Ulm):
Android Obesity in Women as Coronary Risk Factor
............. 335
M. Week (Dresden):
Importance of Correction of Overweight for the Coronary Risk Factor
Profile
...................................... 345
M, J. Halpern, M, F, Mesqvita (Lisbon):
NormolipemicDyslipemia
........................... 352
Interrelationship between Lipoproteins and Hemostasis
G. Siegert, A. Janke, W.
Jaroß
(Dresden):
The Influence of Lipoproteins on Fibrinolydc Activity
............ 357
M. Cucuianu
(Cluj):
Antifibrinolytic Potential in Hyperlipoproteincmia
.............. 363
W. Leonhardt (Dresden):
Factors of Influence on Plasma Viscosity and Density
............. 369
IX
G.
Siegen,
J.
Heinrich,
H.
Schulte,
S.
Bergmann,
Ci. Assmann,
W.
Jarolì
(Dresden, Münster):
Relationship of
Plasminogli
Activator
Inhibitor, Fibrinogen and Anti-
tlirombin
Ш
to other Risk Factors of Atherosclerosis: Results of the
DRECAN Study
.........,....................... 375
Quality Control of Risk Indicators
D.
Graf neuer (Heidelberg):
Twenty Years of the WHO
Lipid
Reference Centre. Experience with Exter¬
nal Quality Control of
Lipid
and Apolipoprotein Methods in International
Studies
...................................... 382
H. Reinauer,
R. Hanke
(Düsseldorf):
External Quality Control of Determinations of Lipicls and Lipoproteins
. . . 389
I. Penttilii, J.
Gaven,
A. Julkunen, M. Siloaho,
S. Väisänen
(Kuopio,
Helsinki)
:
Quality Control of Lipids and Apolipoproteins in Nordic Countries and of
Coagulation Analysis in Finland
........................ 396
F.
Dati
(Marburg);
Standardization and Quality Control in Lipoprotein Analysis and Coagula¬
tion Testing
................................... 401
List of Authors
................................. 407
Subject Index
.................................. 419
Acknowledgement
............................... 426
|
any_adam_object | 1 |
author_GND | (DE-588)105670286 |
building | Verbundindex |
bvnumber | BV004690868 |
classification_tum | OEK 412f MED 441f |
ctrlnum | (OCoLC)28115990 (DE-599)BVBBV004690868 |
discipline | Ökotrophologie Medizin |
format | Conference Proceeding Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02179nam a2200493 c 4500</leader><controlfield tag="001">BV004690868</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20060908 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">911216s1991 ad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3334603970</subfield><subfield code="9">3-334-60397-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)28115990</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004690868</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-M49</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">OEK 412f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 441f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in lipoprotein and atherosclerosis research</subfield><subfield code="b">diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991</subfield><subfield code="c">ed.: M. Hanefeld ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Jena ; Stuttgart ; New York</subfield><subfield code="b"><<G.>> Fischer</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">426 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arteriosclerosis</subfield><subfield code="x">diagnosis</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arteriosclerosis</subfield><subfield code="x">etiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arteriosclerosis</subfield><subfield code="x">therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipoproteins</subfield><subfield code="x">metabolism</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arteriosklerose</subfield><subfield code="0">(DE-588)4068866-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1991</subfield><subfield code="z">Dresden</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arteriosklerose</subfield><subfield code="0">(DE-588)4068866-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arteriosklerose</subfield><subfield code="0">(DE-588)4068866-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hanefeld, Markolf</subfield><subfield code="d">1935-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)105670286</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">International Dresden Lipid Symposium</subfield><subfield code="n">7</subfield><subfield code="d">1991</subfield><subfield code="c">Dresden</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)2120580-2</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung TU Muenchen</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002879788&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002879788</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1991 Dresden gnd-content |
genre_facet | Konferenzschrift 1991 Dresden |
id | DE-604.BV004690868 |
illustrated | Illustrated |
indexdate | 2024-07-09T16:16:09Z |
institution | BVB |
institution_GND | (DE-588)2120580-2 |
isbn | 3334603970 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002879788 |
oclc_num | 28115990 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM DE-12 DE-M49 DE-BY-TUM |
owner_facet | DE-19 DE-BY-UBM DE-12 DE-M49 DE-BY-TUM |
physical | 426 S. Ill., graph. Darst. |
publishDate | 1991 |
publishDateSearch | 1991 |
publishDateSort | 1991 |
publisher | <<G.>> Fischer |
record_format | marc |
spelling | Advances in lipoprotein and atherosclerosis research diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991 ed.: M. Hanefeld ... Jena ; Stuttgart ; New York <<G.>> Fischer 1991 426 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Literaturangaben Arteriosclerosis diagnosis Congresses Arteriosclerosis etiology Congresses Arteriosclerosis therapy Congresses Lipoproteins metabolism Congresses Arteriosklerose (DE-588)4068866-5 gnd rswk-swf Lipidstoffwechselstörung (DE-588)4035876-8 gnd rswk-swf Hyperlipidämie (DE-588)4161072-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1991 Dresden gnd-content Arteriosklerose (DE-588)4068866-5 s Lipidstoffwechselstörung (DE-588)4035876-8 s DE-604 Hyperlipidämie (DE-588)4161072-6 s Hanefeld, Markolf 1935- Sonstige (DE-588)105670286 oth International Dresden Lipid Symposium 7 1991 Dresden Sonstige (DE-588)2120580-2 oth Digitalisierung TU Muenchen application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002879788&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Advances in lipoprotein and atherosclerosis research diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991 Arteriosclerosis diagnosis Congresses Arteriosclerosis etiology Congresses Arteriosclerosis therapy Congresses Lipoproteins metabolism Congresses Arteriosklerose (DE-588)4068866-5 gnd Lipidstoffwechselstörung (DE-588)4035876-8 gnd Hyperlipidämie (DE-588)4161072-6 gnd |
subject_GND | (DE-588)4068866-5 (DE-588)4035876-8 (DE-588)4161072-6 (DE-588)1071861417 |
title | Advances in lipoprotein and atherosclerosis research diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991 |
title_auth | Advances in lipoprotein and atherosclerosis research diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991 |
title_exact_search | Advances in lipoprotein and atherosclerosis research diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991 |
title_full | Advances in lipoprotein and atherosclerosis research diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991 ed.: M. Hanefeld ... |
title_fullStr | Advances in lipoprotein and atherosclerosis research diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991 ed.: M. Hanefeld ... |
title_full_unstemmed | Advances in lipoprotein and atherosclerosis research diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991 ed.: M. Hanefeld ... |
title_short | Advances in lipoprotein and atherosclerosis research |
title_sort | advances in lipoprotein and atherosclerosis research diagnostics and treatment proceedings of the 7th international dresden lipid symposium 1991 held at dresden june 9 11 1991 |
title_sub | diagnostics and treatment ; proceedings of the 7th International Dresden Lipid Symposium 1991, held at Dresden, June 9 - 11, 1991 |
topic | Arteriosclerosis diagnosis Congresses Arteriosclerosis etiology Congresses Arteriosclerosis therapy Congresses Lipoproteins metabolism Congresses Arteriosklerose (DE-588)4068866-5 gnd Lipidstoffwechselstörung (DE-588)4035876-8 gnd Hyperlipidämie (DE-588)4161072-6 gnd |
topic_facet | Arteriosclerosis diagnosis Congresses Arteriosclerosis etiology Congresses Arteriosclerosis therapy Congresses Lipoproteins metabolism Congresses Arteriosklerose Lipidstoffwechselstörung Hyperlipidämie Konferenzschrift 1991 Dresden |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002879788&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT hanefeldmarkolf advancesinlipoproteinandatherosclerosisresearchdiagnosticsandtreatmentproceedingsofthe7thinternationaldresdenlipidsymposium1991heldatdresdenjune9111991 AT internationaldresdenlipidsymposiumdresden advancesinlipoproteinandatherosclerosisresearchdiagnosticsandtreatmentproceedingsofthe7thinternationaldresdenlipidsymposium1991heldatdresdenjune9111991 |